How can I trust the quality of the medical dressing consumables?

We monitor production online in real time and we a professional quality control team who inspects each order before shipment.

Premium Scar Treatment Sheet for Unwanted Scar Minimization

Name: Premium Scar Treatment Sheet for Unwanted Scar Minimization
Brand: Contiwin Co., Ltd
SKU: 2307281275

Shanghai, ChinaContiwin Co., Ltd

US$2.00-50.00

300 Bags

Product specifications

A/B

Sample price:US$5.00/bag.Request sample

Product profile

Customization

Available

Function

Scar Revision

Skin Type

Anywhere on The Body

Model NO.

A, B, C, D

Body Part

Anywhere on The Body

Gender

Adlut,Children

Age Group

Adlut,Children

Shelf Life

3 Years

Package

Color Box

Description

Advanced Silicone Gel Scar for Scars

Feature

Anti-Allergy, Ventilation, Waterproof

Type

Interaction Dressing

Transport Package

Carton

Specification

30*45*10

Trademark

OEM ODM

Origin

Chinese

HS Code

3006500000

Production Capacity

10000000pieces/Year

Key features

Breathable Formula: Advanced silicone gel designed for ventilati on any body part.

Scar Repair Function: Effectively treats both old and new scars with anti-allergy properties.

Waterproof Design: Waterproof and easy to clean, suitable for daily use on any skin type.

Long Shelf Life: Product maintains quality and efficacy for up to 3 years from manufacture.

OEM/ODM Acceptable: Custom branding and manufacturing services available for bulk orders.

Sample Availability: Free or paid samples are available for testing before bulk purchase.

Fast Off-Season Delivery: Lead time within 15 workdays during off-peak seasons.

Global Market Reach: Serving major markets including North America, Europe, and Southeast Asia.

Company profile

Contiwin Co., Ltd

Shanghai, China

Business Type: Manufacturer/FactoryAverage Response Time: ≤0.22h

AI-Powered supplier vetting

SummaryContiwin Co., Ltd is a China-based limited company established in 2020 and identified as a trading company, with an export license and export sales share of 71%–90%. The supplier reports more than 10 production lines, 31–40 quality-control staff, and stated output for hemodialyser flux and A-V blood lines, but other data identifies only three total employees and zero cooperative suppliers, creating internal consistency concerns. Lead times are within 15 workdays in both peak and off-season periods. Overseas infrastructure is limited to participation in an offline medical equipment exhibition; no overseas warehouses, showrooms, agents, branches, or service countries are reported. Quality-system evidence is incomplete: test equipment is listed as zero, complaint procedures and service corrective-action procedures are absent, and quality assurance and traceability status are unknown. No new products, ODM, OEM for popular brands, or SDK are reported. Financial-capacity records are present for multiple years,...

Supplier typeThe supplier is identified as Contiwin Co., Ltd, a China-based limited company established in 2020 and classified as a trading company. Its stated business scope includes medical instruments, production, and import-export services, while no larger-company affiliation is reported.

CertificationsThe supplier explicitly reports holding a valid import and export license. No other certification, quality-system certificate, or product certification is identified in the provided slices, so the assessment is limited to export licensing.

After-Sales capabilityThe supplier reports no written customer-complaint procedures or records, no written service-capability assessment or corrective-action procedures, and no overseas warehouses, showrooms, agents, branches, or service countries. It has participated in one offline medical equipment exhibition and reports lead times within 15 workdays, but these do not establish strong after-sales support.

R&D capabilityThe supplier reports one R&D engineer whose stated responsibility is providing samples to customer requirements. It reports no new products in the past year, no ODM service, no OEM for popular brands, and no available SDK, indicating limited demonstrated innovation capability.